Koyfin Home > Directory > Health Care > Aimmune Therap > Total Debt / EBITDA

Aimmune Therap Total Debt / EBITDA Chart (AIMT)

Aimmune Therap annual/quarterly Total Debt / EBITDA from 2018 to 2020.
  • Aimmune Therap Total Debt / EBITDA for the quarter ending June 06, 2020 was $-1m a 62.32% decrease of 0m year over year
  • Aimmune Therap Total Debt / EBITDA for the last 12 months ending June 06, 2020 was $-1m a 56.63% decrease of 0m year over year
  • Aimmune Therap Annual Total Debt / EBITDA for 2019 was $0m a 99.84% decrease of 0m from 2018
  • Aimmune Therap Annual Total Debt / EBITDA for 2018 was $0m
Other Ratios Metrics:
  • Aimmune Therap Total Debt / Capital for the quarter ending December 12, 2017 was $0m
  • Aimmune Therap Other Liabilities for the quarter ending December 12, 2018 was $3m a 9.82% increase of 0m year over year
  • Aimmune Therap Total Debt / Equity for the quarter ending December 12, 2017 was $0m
View Chart On Koyfin

Quarterly AIMT Total Debt / EBITDA Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m

Annual AIMT Total Debt / EBITDA Data

2019$0m
2018$0m